The pace of AI-driven materials discovery has fundamentally shifted. What once took decades to accomplish now happens in months. Three years of tracking emerging technologies reveals a pattern that should reshape how we think about scientific progress: innovations are moving from laboratory concepts to real-world impact faster than ever before, and AI materials science is leading the charge.

What Changed in AI Materials Discovery Since 2024?

In 2024, breakthroughs in AI were already helping scientists make discoveries that would have been nearly impossible just years earlier. But the field has since accelerated exponentially. In October 2024, the Nobel Prize in Chemistry was awarded to David Baker for computational protein design, and to Demis Hassabis and John Jumper of DeepMind for AlphaFold, an AI model that solved one of biology's most stubborn problems: predicting the three-dimensional structure of proteins. This challenge had defeated researchers for 50 years.

AlphaFold accomplished what seemed impossible. It predicted the structure of virtually all roughly 200 million known proteins in a matter of months. The implications are still unfolding across the scientific world. AlphaFold is now accelerating drug discovery for diseases including cancer, malaria, and Parkinson's. Researchers who once spent entire careers solving a single protein structure are now asking entirely different questions about disease mechanisms and treatment approaches.

"We've gone from emerging technology to Nobel Prize in a single calendar year. In science, that's not acceleration, that's a change in the unit of time," stated Thomas Hartung, Field Chief Editor for Frontiers in Artificial Intelligence.

Thomas Hartung, Field Chief Editor, Frontiers in Artificial Intelligence

How Is AI Reshaping Materials Science Beyond Proteins?

The acceleration extends far beyond protein folding. The same momentum that propelled AlphaFold is now reshaping how scientists approach materials discovery across multiple domains. When emerging technologies are identified early, society gains time to prepare for their impact. The 2024 and 2025 reports highlighted several areas where AI is fundamentally changing the research timeline.

One striking example involves genomics for transplants. In March 2024, surgeons at Massachusetts General Hospital performed the world's first successful transplant of a gene-edited pig kidney into a living human patient. The pig's genome had been edited using CRISPR-Cas9 to remove genes that would trigger rejection and add human genes to improve compatibility. The patient's body accepted it. Since then, multiple further procedures have been completed at MGH, and NYU Langone has launched the first FDA-approved clinical trial, with results now being published in the New England Journal of Medicine.

This matters because more than 100,000 people are on kidney transplant waiting lists in the United States alone. While this technology won't reach all of them in the near future, the move from theory to lab, and now to operating theatre, demonstrates that the question is no longer whether this is possible, but how far it can go.

Steps to Understanding AI's Role in Modern Materials Science

• Protein Structure Prediction: AI models like AlphaFold can now predict how proteins fold in three dimensions, a task that previously required years of laboratory work and is now used to accelerate drug discovery for major diseases.
• Genetic Engineering Applications: AI-assisted genomics enables researchers to design and edit biological materials, such as pig organs for human transplantation, by identifying which genes to modify for compatibility.
• Timeline Compression: What once took decades of research now happens in months, allowing scientists to move from computational design directly to clinical trials and real-world deployment.

Why Does the Speed of Discovery Matter?

The acceleration in AI materials science has profound implications for how quickly solutions reach people who need them. When researchers can move from identifying a problem to designing a solution in months rather than years, the human impact compounds. Drug development timelines shrink. Transplant options expand. The bottleneck shifts from "Can we solve this?" to "How do we scale and deploy this safely?".

The Nobel Prize recognition of AlphaFold in 2024 was not just an award for past achievement. It was a signal that AI-driven materials discovery had matured from an emerging technology into a foundational tool for science itself. The Committee called it "a revolutionary tool for understanding life." That revolution is now reshaping drug pipelines, transplant medicine, and how scientists approach problems they once considered intractable.

The 2026 Emerging Technologies report has identified 10 more innovations with the potential to shape the world around us. If the momentum of the past three years is any guide, their impact may be felt sooner than expected. The unit of time for scientific progress has fundamentally changed.